We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Parkinson's Research: The Organized Genetics Initiative (PROGENI)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00086073
First Posted: June 24, 2004
Last Update Posted: February 16, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
The Parkinson Study Group
Children's Hospital Medical Center, Cincinnati
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by:
Indiana University
June 22, 2004
June 24, 2004
February 16, 2011
August 1998
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00086073 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Parkinson's Research: The Organized Genetics Initiative
Parkinson's Disease Collaborative Study of Genetic Linkage
The purpose of this trial is to study genetic and other risk factors that may be important in the development of Parkinson's disease.

The The Parkinson's Research: The Organized Genetics Initiative, also known as PROGENI, is a multi-center study involving 2000 people throughout North America who are affected, or possibly affected, with Parkinson's disease (PD). The goal of the initiative is to study the genetic and other risk factors which may be important in the development of PD.

In order to better understand the genetic factors leading to PD, researchers will study families having 2 or more members diagnosed with PD. Using DNA samples from each participant, researchers hope to identify genes that may cause a person to be at higher risk for developing PD.

Each participant in the study will be asked to complete a family history questionnaire, providing information about the history of PD in the family. Participants also will be asked to discuss the symptoms they have experienced and their responses to PD medications. This information will be used by study personnel to determine further eligibility for the study. Those eligible for further participation will be asked to undergo a study visit at the site closest to their residence, during which they will be asked to complete questionnaires regarding PD symptoms, medical history, places of residence, occupations, mood, mental status, and activity level. A blood sample will be drawn for DNA extraction. The study visit will take about 2 hours.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
blood sample
Non-Probability Sample
families having 2 or more members diagnosed with PD
Parkinson Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1800
January 2011
Not Provided

Inclusion Criteria:

  • To be eligible to participate in this study participants must be diagnosed with or have symptoms of PD. In addition, they must also have a family history of PD in other relatives.

Exclusion Criteria:

  • Subjects cannot have participated in any other genetic research project for Parkinson's disease.
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Canada,   Puerto Rico,   United States
 
 
NCT00086073
9703-09
R01NS037167 ( U.S. NIH Grant/Contract )
No
Not Provided
Not Provided
Tatiana Foroud, Ph.D, Principal Investigator, Indiana University
Indiana University School of Medicine
  • The Parkinson Study Group
  • Children's Hospital Medical Center, Cincinnati
  • National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator: Tatiana Foroud, Ph.D. Indiana University
Indiana University
November 2010